NVCR

SEC source: 0001645113-22-000064 · wf-form4_165723055863070.xml · nonDerivative · entry 1

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,139

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.

SEC source: 0001645113-22-000062 · wf-form4_165723047506853.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,583

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.

SEC source: 0001645113-22-000061 · wf-form4_165723043635515.xml · nonDerivative · entry 1

Benaim Ely · CIK 0001632237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,068

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.

SEC source: 0001645113-22-000060 · wf-form4_165723038363274.xml · nonDerivative · entry 1

Leonard Frank X · CIK 0001822879 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,607

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.

SEC source: 0001645113-22-000059 · wf-form4_165723033557650.xml · nonDerivative · entry 1

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,499

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.

SEC source: 0001645113-22-000057 · wf-form4_165541090953677.xml · nonDerivative · entry 1

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,537

F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman.

SEC source: 0001645113-22-000055 · wf-form4_165489194524345.xml · derivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,700

Underlying: Ordinary Shares · 8,700 shares

Expires 2032-06-08

F1 · derivative.exercise_date: Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000053 · wf-form4_165489184116868.xml · derivative · entry 1

Scannell Timothy J · CIK 0001451533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,700

Underlying: Ordinary Shares · 8,700 shares

Expires 2032-06-08

F1 · derivative.exercise_date: Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000054 · wf-form4_165489189409829.xml · derivative · entry 2

Hung David · CIK 0001310880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

Underlying: Ordinary Shares · 4,350 shares

Expires 2032-06-08

F2 · derivative.exercise_date: Options to buy 4,350 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000054 · wf-form4_165489189409829.xml · nonDerivative · entry 1

Hung David · CIK 0001310880 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,141

F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000052 · wf-form4_165489178577472.xml · derivative · entry 1

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,700

Underlying: Ordinary Shares · 8,700 shares

Expires 2032-06-08

F1 · derivative.exercise_date: Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000051 · wf-form4_165489173935006.xml · derivative · entry 2

LEUNG GABRIEL · CIK 0001236183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

Underlying: Ordinary Shares · 4,350 shares

Expires 2032-06-08

F2 · derivative.exercise_date: Options to buy 4,350 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000051 · wf-form4_165489173935006.xml · nonDerivative · entry 1

LEUNG GABRIEL · CIK 0001236183 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,286

F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000050 · wf-form4_165489168529039.xml · derivative · entry 1

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,700

Underlying: Ordinary Shares · 8,700 shares

Expires 2032-06-08

F1 · derivative.exercise_date: Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.

SEC source: 0001645113-22-000046 · wf-form4_165238737966787.xml · nonDerivative · entry 2

Benaim Ely · CIK 0001632237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,846

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000046 · wf-form4_165238737966787.xml · nonDerivative · entry 1

Benaim Ely · CIK 0001632237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,981

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Amended total to correct prior mathematical error.

SEC source: 0001645113-22-000045 · wf-form4_165212724938002.xml · derivative · entry 2

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,048

Underlying: Ordinary Shares · 1,324 shares

Expires 2026-01-12

F1 · derivative.exercise_date: Currently exercisable.

SEC source: 0001645113-22-000045 · wf-form4_165212724938002.xml · derivative · entry 1

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,324 shares

Expires 2026-01-12

F1 · derivative.exercise_date: Currently exercisable.

F2 · ownership.nature: By The 2020 Groenhuysen Annuity Trust. Mr. Groenhuysen does not disclaim beneficial ownership.

SEC source: 0001645113-22-000031 · wf-form4_164703562615399.xml · nonDerivative · entry 2

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,187

F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.

F2 · balance_after: Amended total to correct prior mathematical error.

SEC source: 0001645113-22-000028 · wf-form4_164686280769622.xml · nonDerivative · entry 1

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,991

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000025 · wf-form4_164686256918260.xml · nonDerivative · entry 1

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,462

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000027 · wf-form4_164686273565625.xml · nonDerivative · entry 1

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,102

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000030 · wf-form4_164686295456528.xml · nonDerivative · entry 2

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,908

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000029 · wf-form4_164686288571914.xml · nonDerivative · entry 1

Leonard Frank X · CIK 0001822879 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,295

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000026 · wf-form4_164686266443195.xml · nonDerivative · entry 1

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,848

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · balance_after: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000024 · wf-form4_164686246214915.xml · nonDerivative · entry 1

DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 552,013

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000030 · wf-form4_164686295456528.xml · nonDerivative · entry 1

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,389

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000016 · wf-form4_164669502376914.xml · nonDerivative · entry 3

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,028

F2 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000023 · wf-form4_164669568882280.xml · nonDerivative · entry 2

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,801

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000022 · wf-form4_164669559462387.xml · nonDerivative · entry 3

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,607

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000020 · wf-form4_164669542266568.xml · nonDerivative · entry 4

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,683

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000020 · wf-form4_164669542266568.xml · nonDerivative · entry 3

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,597

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000017 · wf-form4_164669511463233.xml · nonDerivative · entry 3

Benaim Ely · CIK 0001632237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,257

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000015 · wf-form4_164669495236747.xml · nonDerivative · entry 3

GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,025

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000014 · wf-form4_164669485933981.xml · nonDerivative · entry 3

Leonard Frank X · CIK 0001822879 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,039

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000016 · wf-form4_164669502376914.xml · derivative · entry 5

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,361

Underlying: Ordinary Shares · 4,361 shares

Expires 2032-02-29

F4 · shares: Options to buy 4,361 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000016 · wf-form4_164669502376914.xml · derivative · entry 4

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,038

Underlying: Ordinary Shares · 13,038 shares

Expires 2032-02-29

F3 · shares: Options to buy 13,038 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000016 · wf-form4_164669502376914.xml · nonDerivative · entry 2

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,054

F2 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000016 · wf-form4_164669502376914.xml · nonDerivative · entry 1

Burke William Patrick · CIK 0001880493 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,395

F1 · kind: Represents restricted share units that are scheduled to vest in equal installments on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000021 · wf-form4_164669550591279.xml · derivative · entry 3

Weinberg Uri · CIK 0001811030 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,961

Underlying: Ordinary Shares · 4,961 shares

Expires 2032-02-29

F3 · shares: Options to buy 4,961 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000021 · wf-form4_164669550591279.xml · derivative · entry 2

Weinberg Uri · CIK 0001811030 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,422

Underlying: Ordinary Shares · 30,422 shares

Expires 2032-02-29

F2 · shares: Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000021 · wf-form4_164669550591279.xml · nonDerivative · entry 1

Weinberg Uri · CIK 0001811030 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,186

F1 · shares: Represents restricted share units that are scheduled to vest on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000023 · wf-form4_164669568882280.xml · derivative · entry 3

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,106

Underlying: Ordinary Shares · 6,106 shares

Expires 2032-02-29

F2 · shares: Options to buy 6,106 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000023 · wf-form4_164669568882280.xml · nonDerivative · entry 1

Longsworth Todd Christopher · CIK 0001693530 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,774

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000022 · wf-form4_164669559462387.xml · derivative · entry 5

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,140

Underlying: Ordinary Shares · 5,140 shares

Expires 2032-02-29

F4 · shares: Options to buy 5,140 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000022 · wf-form4_164669559462387.xml · derivative · entry 4

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,664

Underlying: Ordinary Shares · 37,664 shares

Expires 2032-02-29

F3 · shares: Options to buy 37,664 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000022 · wf-form4_164669559462387.xml · nonDerivative · entry 2

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,163

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

SEC source: 0001645113-22-000022 · wf-form4_164669559462387.xml · nonDerivative · entry 1

Cordova Ashley · CIK 0001822014 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,312

F1 · shares: Represents restricted share units that are scheduled to vest in equal installments on each of March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000019 · wf-form4_164669531950813.xml · derivative · entry 1

Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,470

Underlying: Ordinary Shares · 13,470 shares

Expires 2032-02-29

F1 · shares: Options to buy 13,470 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.

SEC source: 0001645113-22-000020 · wf-form4_164669542266568.xml · derivative · entry 6

Shah Pritesh · CIK 0001744884 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,231

Underlying: Ordinary Shares · 6,231 shares

Expires 2032-02-29

F4 · shares: Options to buy 6,231 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.